Belmar Pharmacy
“Prescriptions issued by clinicians on the platform are dispensed by the following US-licensed partner pharmacies: Belmar Pharmacy - 800-525-9473 - belmarpharmasolutions.com”
Source: www.pallashealth.co · Verified 2026-08-07
Pallas Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8/10
Best for: knowing which pharmacy fills the vial — it names Belmar Pharmacy
8.0
★★★★☆4/5
Pallas Health's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
$139first month
then $199/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
See plans →See plans at Pallas Health →
No insurance needed · Vetted by our editors
$199 and $299 a month are the averages on the compounded plans, with messaging, check-ins and provider care folded in, no membership charged on the side, and the figure unchanged at every dose. Mounjaro, Zepbound, Ozempic and Wegovy sell under their brand names next to compounded tirzepatide and semaglutide. Brentmoor, Inc. is the operator. Disclosure is unusually thorough here: NPIs you can verify against two named advising physicians, Lion MD as clinical partner, six pharmacy partners named, and all 50 states plus DC covered.
By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GLP-1 from $199/moPrice shown up frontFlat across dosesIncludes medication + consultAll 50 statesPharmacy namedNo FDA letter on record
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Pallas Health at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $139/mo ($139 for the first month, then $597 every 12 weeks, which Pallas advertises as a $199/mo average. Same price at every...)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How Pallas Health scores
Six columns, each one computed from something Pallas Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
4.6/10$199/month is 5% above the register median of $189 for compounded semaglutide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
10.0/10names its dispensing pharmacy; shows a price before asking for health information; publishes its state list. Our verification confidence is high.
Accessibility10%
10.0/10Publishes coverage in 51 of 50 states.
Support10%
7.0/10The price covers medication, consult, shipping.
6weighted dimensions
560sellers in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Pallas Health
Last checked August 2026- Re-read the price on file across 2 dose or plan tiers
- Checked state coverage: all 50
- Established what the monthly figure covers, and what it leaves out
- Confirmed which compounding pharmacy fills the order, and its accreditation
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: high.
What signing up with Pallas Health involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1Pallas Health publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3A prescription is dispensed by Belmar Pharmacy, which Pallas Health names publicly. Most sellers in this register do not.
- 4The monthly price is recorded as covering medication, consult, shipping.
Price shown before you start
- Cheapest standing monthly prices on record: semaglutide $199, tirzepatide $299. Membership fees, first-month rates and insured copays are excluded from those figures.
- Coverage is published for all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
GLP-1 medications Pallas Health offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Peptides Pallas Health offers
Pallas Health sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Compounded plan, billed $597 every 12 weeks (not monthly)Compounded
$199$139/mo
Save 30% right nowsemaglutide
$139 for the first month, then $597 every 12 weeks, which Pallas advertises as a $199/mo average. Same price at every dose. Provider care and check-ins included.
Compounded plan, billed $897 every 12 weeks (not monthly)Compounded
$299$179/mo
Save 40% right nowtirzepatide
$179 for the first month, then $897 every 12 weeks, advertised as a $299/mo average. Same price at every dose.
Check the price yourself before you pay
Every figure here was read off Pallas Health's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Pallas Health compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that Pallas Health routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
Strive Pharmacy
“Strive Pharmacy - 855-405-5993 - strivepharmacy.com”
Source: www.pallashealth.co · Verified 2026-08-07
Epiq Scripts
“Epiq Scripts - 833-654-3553 - epiqscripts.com”
Source: www.pallashealth.co · Verified 2026-08-07
Casa Pharma Rx
“Casa Pharma Rx - 877-937-6868 - casapharmarx.com”
Source: www.pallashealth.co · Verified 2026-08-07
The Pharmacy Hub
- License footprint
- 1 states: FL
“The Pharmacy Hub - 888-958-1382 - thepharmacyhub.com”
Source: www.pallashealth.co · Verified 2026-08-07
Foothills Pharmacy
“Foothills Pharmacy - 480-496-4444 - foothillspharmacy.com”
Source: www.pallashealth.co · Verified 2026-08-07
In its favor
- Semaglutide at $199 a month, within the normal band around this register's $189 median for the same drug and form
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping
- Coverage is published for all 50 states
- Names 6 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Pallas Health charges
The figure Pallas Health leads with is $139, and it is a first-month rate. From month two the price is $199/month, which is the number to plan around. Nothing improper about an introductory offer — it just is not the price of staying on the medication.
- Compounded semaglutide — $139 first month, then $199/month
- Compounded tirzepatide — $179 first month, then $299/month
The median standing price across the GLP-1 providers we track is about $169/month, so this is a premium, and a premium has to buy something. Discounting the first month does not change the twelve-month total by much.
Found dispenses semaglutide and tirzepatide from $149/month, which makes it the honest comparison to run before committing here.
What Pallas Health dispenses
Pallas Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
What we could verify
On the record: it treats patients in all 50 states and it names the pharmacy that fills its prescriptions. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded, the named pharmacy is the detail that matters most here — it is the license you can actually look up. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You are optimizing for the twelve-month total rather than the first bill — a flat-rate seller such as CoreAge Rx will usually win that arithmetic.
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will be paying in month three.
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- you want the price to stop moving as your dose climbs
- you want a cheap way to find out whether the medication suits you before committing
- you need access regardless of where you live
Our read
Pallas Health is a cheap way to start and an ordinary way to continue. Use the $139 month for what it is good for — establishing whether the medication works for you — and re-run the numbers against $199/month before you let it renew twice. Breeze Meds is the nearest comparison we track, and worth reading alongside this.
The Bottom Line
Pallas Health's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Score: 8/10Best for: knowing which pharmacy fills the vial — it names Belmar PharmacyFrom: $139/mo
Before you pay Pallas Health
Starting at $139/month. Check today's price, then book the free consultation.
Where Pallas Health is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Alternatives to Pallas Health
★★★★☆4/5
Editorial score · methodology
$119/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full Oak review →★★★☆☆3.3/5
Editorial score · methodology
$249/mo
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →★★★★☆4.4/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Pallas Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Pallas Health's current pricing
Plans start at $139/month. The free consultation is where you learn whether you qualify, and what it costs today.
From $139/mo
Pallas Health